Showing results (341-350 of 607) with videos related to
Sort By:
Pageof 61
FEBS Letters|May 8, 2010
The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicityIuliana Ristea Popescu, Audrey Helleboid-Chapman, Anthony Lucas, et al.Hepatology (Baltimore, Md.)|May 13, 2020
Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)Jimmy Vandel, Julie Dubois-Chevalier, Céline Gheeraert, et al.Shock (Augusta, Ga.)|February 27, 2014
Impact of endotoxin challenge in obese pigsThibault Duburcq, Thomas Hubert, Pierre Saint-Léger, et al.Journal of Medicinal Chemistry|August 19, 2005
Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activityAlessandra Pinelli, Cristina Godio, Antonio Laghezza, et al.Proceedings of the National Academy of Sciences of the United States of America|October 26, 2005
A fully dissociated compound of plant origin for inflammatory gene repressionKarolien De Bosscher, Wim Vanden Berghe, Ilse M E Beck, et al.Bioorganic & Medicinal Chemistry Letters|April 21, 2009
4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part. II: Synthesis and pharmacological evaluation of oxime and acidic head group structural variationsCécile Parmenon, Jérôme Guillard, Daniel-Henri Caignard, et al.Neurology|March 1, 2020
Analysis of the association of MPO and MMP-9 with stroke severity and outcome: Cohort studyIlaria Maestrini, Madjid Tagzirt, Sophie Gautier, et al.The Journal of Biological Chemistry|May 19, 2005
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transitionDaniel Duran-Sandoval, Bertrand Cariou, Fredéric Percevault, et al.Bioorganic & Medicinal Chemistry Letters|June 8, 2007
Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonistsYukiyoshi Yamazaki, Kazutoyo Abe, Tsutomu Toma, et al.Journal of Lipid Research|March 13, 2013
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth-muscle cell proliferation and neointima formationFilippo Molica, Fabienne Burger, Aurélien Thomas, et al.Pageof 61